Neal Walker
2020
In 2020, Neal Walker earned a total compensation of $1.6M as President and Chief Executive Officer at Aclaris Therapeutics, a 49% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $407,880 |
|---|---|
| Option Awards | $231,784 |
| Salary | $423,784 |
| Stock Awards | $535,830 |
| Other | $11,400 |
| Total | $1,610,678 |
Walker received $535.8K in stock awards, accounting for 33% of the total pay in 2020.
Walker also received $407.9K in non-equity incentive plan, $231.8K in option awards, $423.8K in salary and $11.4K in other compensation.
Rankings
In 2020, Neal Walker's compensation ranked 6,526th out of 13,090 executives tracked by ExecPay. In other words, Walker earned more than 50.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,526 out of 13,090 | 50th |
Division Manufacturing | 2,694 out of 5,624 | 52nd |
Major group Chemicals And Allied Products | 1,086 out of 2,257 | 52nd |
Industry group Drugs | 940 out of 1,957 | 52nd |
Industry Pharmaceutical Preparations | 703 out of 1,462 | 52nd |
Source: SEC filing on April 21, 2022.
Walker's colleagues
We found three more compensation records of executives who worked with Neal Walker at Aclaris Therapeutics in 2020.